Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELEXIPAG vs SELUMETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SELEXIPAG vs SELUMETINIB: Safety Overview

Metric SELEXIPAG SELUMETINIB
Total FAERS Reports 18,471 1,172
Deaths Reported 3,778 81
Death Rate 20.5% 6.9%
Hospitalizations 9,394 211
Average Patient Age 58.4 yrs 25.6 yrs
% Female Patients 71.9% 51.6%
FDA Approval Date Dec 21, 2015 Apr 10, 2020
Manufacturer Zydus Pharmaceuticals (USA) Inc. AstraZeneca Pharmaceuticals LP
Route ORAL ORAL
Marketing Status Prescription Prescription